OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
Pegah Golabi, Soroor Owrangi, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 15

Showing 15 citing articles:

Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
Yanyan Xuan, Fang-Fang He, Qing Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Inhibition of IRE‐1α Alleviates Pyroptosis and Metabolic Dysfunction‐Associated Steatohepatitis by Suppressing Gasdermin D
Xin Zeng, Tian Wu, Qing Xu, et al.
Liver International (2025) Vol. 45, Iss. 2
Closed Access

Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction–associated steatotic liver disease
Alina M. Allen, Jeffrey V. Lazarus, Naim Alkhouri, et al.
Hepatology Communications (2025) Vol. 9, Iss. 5
Open Access

CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
Raanan Greenman, Chris J. Weston
Cells (2025) Vol. 14, Iss. 2, pp. 105-105
Open Access

A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
M. Hong Nguyen, Andrew Lian, Frederick T. Guilford, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 644-644
Open Access

Interplay of the pathophysiological mechanisms of Non-Alcoholic Fatty Liver Disease, Diabetes Mellitus, and Inflammation: A growing threat to public health
Sharon Olabisoye Oladipupo, Emmanuel Henry Ezenabor, Adebola Busola Ojo, et al.
Obesity Medicine (2025), pp. 100613-100613
Closed Access

Are dietary factors associated with cardiometabolic risk factors in patients with non-alcoholic fatty liver disease?
G.G. Topal, Sümeyra Sevim, D. Gümüş, et al.
PeerJ (2024) Vol. 12, pp. e17810-e17810
Open Access

The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency
Ivan Tattoli, Aimee Rachel Mathew, Antonella Verrienti, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1631-1631
Open Access

Association of serum klotho with cognitive function among individuals with nonalcoholic fatty liver disease
Feilong Wu, Jie Pan, Mingtao Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access

Copper oxide nanoparticles induce non-alcoholic fatty liver disease by disrupting bile acid homeostasis and perturbing the intestinal microbial homeostasis
Muran Jiang, Xiaoqi Tao, Yingxin Pang, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 136416-136416
Closed Access

Antibody-Mediated Immune Response and Non-Alcoholic Fatty Liver Disease: A Bidirectional Mendelian Randomization Study
阮昶 陈
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 522-530
Closed Access

Page 1

Scroll to top